Caris Life Sciences, Inc. Common Stock Financial Flexibility Index
Caris Life Sciences, Inc. Common Stock financial flexibility index. Caris Life Sciences, Inc. Common Stock (CAI) has a Financial Flexibility Index of 0.15x as of June 2026. Free cash flow of $93.77 Million (operating CF $61.35 Million minus capex $32.42 Million) represents 0% of total liabilities ($637.89 Million). See Caris Life Sciences, Inc. Common Stock free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Caris Life Sciences, Inc. Common Stock (2005–2025)
Financial flexibility index of Caris Life Sciences, Inc. Common Stock from 2005 to 2025. Historical Financial Flexibility Index trend for Caris Life Sciences, Inc. Common Stock across 20 annual periods. Check CAI operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Caris Life Sciences, Inc. Common Stock Financial Flexibility Index by Year (2005–2025)
Caris Life Sciences, Inc. Common Stock financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Caris Life Sciences, Inc. Common Stock. For the full cash flow conversion analysis, see how efficiently does Caris Life Sciences, Inc. Common Stock generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | $99.42 Million | $83.16 Million | $548.36 Million | ▲ +317.7% |
| 2024 | -0.08x | $-236.75 Million | $-245.20 Million | $2.84 Billion | ▲ +16.1% |
| 2023 | -0.10x | $-253.78 Million | $-276.10 Million | $2.56 Billion | ▲ +1.4% |
| 2022 | -0.10x | $-243.45 Million | $-285.71 Million | $2.42 Billion | ▼ -138.7% |
| 2020 | 0.26x | $496.47 Million | $277.02 Million | $1.91 Billion | ▲ +0.1% |
| 2019 | 0.26x | $573.14 Million | $254.00 Million | $2.21 Billion | ▼ -39.6% |
| 2018 | 0.43x | $992.61 Million | $179.77 Million | $2.31 Billion | ▲ +21.9% |
| 2017 | 0.35x | $657.37 Million | $155.19 Million | $1.87 Billion | ▲ +47.9% |
| 2016 | 0.24x | $380.50 Million | $129.26 Million | $1.60 Billion | ▼ -32.4% |
| 2015 | 0.35x | $536.78 Million | $147.37 Million | $1.53 Billion | ▲ +6.5% |
| 2014 | 0.33x | $447.00 Million | $139.69 Million | $1.35 Billion | ▼ -4.6% |
| 2013 | 0.35x | $436.39 Million | $124.19 Million | $1.26 Billion | ▼ -42.9% |
| 2012 | 0.61x | $631.43 Million | $106.83 Million | $1.04 Billion | ▼ -24.2% |
| 2011 | 0.80x | $564.03 Million | $72.11 Million | $704.63 Million | ▲ +33.5% |
| 2010 | 0.60x | $249.25 Million | $42.42 Million | $415.78 Million | ▲ +136.3% |
| 2009 | 0.25x | $62.15 Million | $30.80 Million | $244.99 Million | ▼ -67.3% |
| 2008 | 0.78x | $231.74 Million | $27.44 Million | $298.84 Million | ▼ -19.4% |
| 2007 | 0.96x | $219.40 Million | $-266.00K | $227.95 Million | ▲ +353.0% |
| 2006 | 0.21x | $54.23 Million | $8.38 Million | $255.25 Million | ▲ +5.4% |
| 2005 | 0.20x | $29.76 Million | $29.41 Million | $147.67 Million | — |